82P Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pacira Biosciences Inc

Watchlist Manager

Watchlist

Price: 28.28 EUR Market Closed

Market Cap: €1.3B

P	Pacira Biosciences Inc XBER:82P	US
F	Fanuc Corp XMUN:FUC	JP
P	Pfizer Inc DUS:PFE	US
R	RTL Group SA DUS:RRTL	LU
P	Pepkor Holdings Ltd JSE:PPH	ZA
S	Sealed Air Corp F:SDA	US
L	Lam Research Corp DUS:LAR	US
	Logan Energy Corp F:R76	CA
M	MEP Corporation PCL SET:MEB	TH
	Relevium Technologies Inc XTSX:RLV	CA

Profitability Summary

Pacira Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

79%

Strong 3Y Average Gross Margin

76%

Gross Margin is Increasing

69% > 79%

Low Operating Margin

Sustainable 3Y Average Operating Margin

10%

Declining Operating Margin

10% > 5%

Low Net Margin

Negative 3Y Average Net Margin

-2%

Net Margin is Increasing

-1% > 2%

Exceptional Free Cash Flow Margin

24%

Strong 3Y Average Free Cash Flow Margin

21%

Free Cash Flow Margin is Increasing

19% > 24%

Low ROE

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.